Discuss the ethical considerations of placebo use in clinical practice.

• A. Placebos always allowed.
• B. Placebos can compromise trust and informed consent; ethically permissible only when no proven therapy exists, with full disclosure of alternatives when feasible and consent obtained.
• C. Placebos are always unethical.
• D. Placebos require no disclosure.

Answer: (B)

Understanding this topic hinges on respecting patient autonomy and maintaining trust in the caregiver–patient relationship. Using a placebo in practice can undermine informed consent if the patient isn’t aware they are receiving a placebo, which challenges their ability to make an informed choice about their care. The ethical path is to be transparent, discuss options, and obtain the patient’s consent.

A placebo may be considered ethically permissible only when there is no proven therapy for the condition being treated. In that situation, the clinician should thoroughly explain that no proven treatment exists, outline available alternatives (including nonpharmacologic options), and obtain the patient’s informed consent before proceeding. This approach honors the patient’s right to know what treatment they are receiving and to decide whether to try a placebo in the context of their care.

If a proven therapy does exist, prescribing or administering a placebo would deprive the patient of effective treatment and violate principles of beneficence and nonmaleficence, making it ethically inappropriate.

In practice, the emphasis is on honesty and patient choice. If a clinician and patient mutually agree, with clear disclosure and consent, a placebo use may be considered only in the absence of proven alternatives. It’s also worth noting that open‑label placebo discussions—where patients know they’re receiving a placebo—reflect ongoing ethical debates but do not replace the fundamental need for transparency and consent.